{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:48:36Z","timestamp":1774615716306,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Istanbul"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T12:08:53Z","timestamp":1545134933000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["In vitro activities of ceftazidime\/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4428-5066","authenticated-orcid":false,"given":"Emel","family":"Matarac\u0131 Kara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna","family":"\u00d6zbek \u00c7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jgar.2018.12.004_bib0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12275-017-7288-4","article-title":"Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy","volume":"55","author":"Shin","year":"2017","journal-title":"J Microbiol"},{"key":"10.1016\/j.jgar.2018.12.004_bib0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.jgar.2018.12.004_bib0015","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.01097-08","article-title":"In vitro activities of tigecycline: minocycline and colistin-tigecycline combinations against multi- and pandrug-resistant clinical \u0131solates of Acinetobacter baumannii group","volume":"53","author":"Arroyo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.jgar.2018.12.004_bib0020","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"Munoz-Price","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jgar.2018.12.004_bib0025","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jgar.2018.12.004_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.diagmicrobio.2009.01.012","article-title":"Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea","volume":"64","author":"Park","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jgar.2018.12.004_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1099\/jmm.0.036939-0","article-title":"In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates","volume":"61","author":"Peck","year":"2012","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.jgar.2018.12.004_bib0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-Lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"Duin","year":"2016","journal-title":"CID"},{"key":"10.1016\/j.jgar.2018.12.004_bib0045","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/AAC.02429-13","article-title":"Antimicrobial activity of ceftazidime-avibactam against gram-negative organisms collected from U.S. medical centers in 2012","volume":"58","author":"Sader","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.004_bib0050","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A7, ed 7, Wayne, PA, USA, 2006."},{"key":"10.1016\/j.jgar.2018.12.004_bib0055","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement-M100-S20. Wayne, PA, USA, 2010."},{"key":"10.1016\/j.jgar.2018.12.004_bib0060","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1073\/pnas.1216691110","article-title":"Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis","volume":"110","author":"Jenner","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgar.2018.12.004_bib0065","unstructured":"National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents-approved guideline M26A. Wayne NCCLS, 1999."},{"issue":"9","key":"10.1016\/j.jgar.2018.12.004_bib0070","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/cid\/civ048","article-title":"Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance","volume":"60","author":"Qureshi","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.004_bib0075","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3201\/eid1506.081006","article-title":"Extensively drug-resistant Acinetobacter baumannii","volume":"15","author":"Doi-Yhusain","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.004_bib0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.diagmicrobio.2009.03.029","article-title":"Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals","volume":"64","author":"Park","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"209","key":"10.1016\/j.jgar.2018.12.004_bib0085","first-page":"1","article-title":"In vitro evaluation of the colistin-carbapenem combination in clinical isolates of Acinetobacter baumannii using the checkerboard, etest, and time-kill curve techniques","volume":"7","author":"Soudehia","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2018.12.004_bib0090","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/AAC.01309-07","article-title":"Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii","volume":"52","author":"Lim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.004_bib0095","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in Acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.004_bib0100","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AAC.00092-13","article-title":"Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design","volume":"57","author":"Landersdorfer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.004_bib0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.diagmicrobio.2008.04.012","article-title":"Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005\/2006","volume":"62","author":"Zhanel","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.004_bib0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-014-2231-7","article-title":"Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin","volume":"34","author":"Safarika","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.004_bib0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/QCO.0b013e32833ae38b","article-title":"Multi-resistant Acinetobacter baumannii infections: epidemiology and management","volume":"23","author":"Garnacho-Montero","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.jgar.2018.12.004_bib0120","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/jac\/dkx002","article-title":"Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity","volume":"72","author":"Lenhard","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jgar.2018.12.004_bib0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkx368","article-title":"Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"73","author":"Kengkla","year":"2018","journal-title":"J Antimicrobial Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T16:47:04Z","timestamp":1560876424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518302480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":25,"alternative-id":["S2213716518302480"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.004","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activities of ceftazidime\/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}